Microbix: Microbix Presenting at Investor Conference in B.C.

MISSISSAUGA, Ontario, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX:MBX, OTCQX: MBXBF, Microbix®), (TSX: MBX, OTCQX:MBXBF, Microbix®), Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to equity investors at the Whistler Capital Event conference, organized by Capital Event Management Ltd. and being hosted at the Fairmont Chateau Whistler, in Whistler, British Columbia, February 21 to 23, 2025.Microbix's CEO, Cameron Groome, will undertake a series of 18 one-on-one meetings with growth company equity investors during the formal portion of the conference. The presentation slides to which he will be speaking will be posted to the Microbix website at https://microbix.com, alongside other business information and its financial disclosures.About Microbix Biosystems Inc.Microbix Biosystems Inc. creates proprietary biological products for human health, with over 120 skilled employees and sales now targeting C$ 2.0 million or more per month. It makes and exports a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs ) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its antigens drive the antibody tests of approximately 100 diagnostics makers, while QAPs are sold to clinical lab accreditation organizations, diagnostics companies, and clinical labs. Microbix QAPs are now available in over 30 ...Full story available on Benzinga.com